Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Johnson & Johnson (J&J) researches, develops, manufactures, and sells pharmaceutical products, medical devices, and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious, cardiovascular, and metabolic diseases; consumer products in oral care, baby care, beauty, over the counter (OTC) medicines, women’s health and wound care categories; and medical devices for use in the cardiovascular, orthopaedic, neurovascular care, general surgery and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, health care professionals and hospitals; and offers consumer products through retail outlets and distributors. The company offers its products in the US; Europe; Asia-Pacific and Africa; and Western Hemisphere (excluding the US). J&J is headquartered in New Brunswick, New Jersey, the US.Johnson & Johnson Key Recent Developments
- Dec 07, 2023: Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
- Nov 30, 2023: Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
- Nov 16, 2023: Johnson & Johnson to Host Enterprise Business Review
- Nov 07, 2023: Fujifilm Diosynth Biotechnologies Announces First Tenant for New Manufacturing Facility
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences, Power Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Sanofi
- Novartis AG
- Abbott Laboratories
- L'Oreal SA
- Cardiovascular Systems Inc
- Boston Scientific Corp
- Beiersdorf AG
- GSK plc
- Stryker Corp
- Mallinckrodt Plc
- Kimberly-Clark Corp
- The Hain Celestial Group Inc
- Takeda Pharmaceutical Co Ltd
- Immunomedics Inc
- Merck & Co Inc
- CR Bard Inc
- ConMed Corp
- Pfizer Inc
- FibroGen Inc
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Co
- L'Oreal SA
- Boston Scientific Corp
- The Hain Celestial Group Inc
- Abbott Laboratories
- GSK plc
- Stryker Corp
- Mallinckrodt Plc
- Kimberly-Clark Corp
- ConMed Corp
- Merck & Co Inc
- CR Bard Inc
- FibroGen Inc
- Sanofi
- Novartis AG
- Cardiovascular Systems Inc
- Beiersdorf AG
- Pfizer Inc
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Co
- Takeda Pharmaceutical Co Ltd
- Immunomedics Inc